Session Details
[IS02☆]International Symposium on Pharmacology and Drug Therapeutics
Sat. Mar 28, 2026 1:10 PM - 3:10 PM JST
Sat. Mar 28, 2026 4:10 AM - 6:10 AM UTC
Sat. Mar 28, 2026 4:10 AM - 6:10 AM UTC
Room 04 (E301, Bldg. 3, Area 2 [3F])
Organizer: Shuntaro Hara (Grad. Sch. Pharm., Showa Med. Univ.), Atsushi Matsuzawa (Grad. Sch. Pharm. Sci., Tohoku Univ.), Hisao Yamamura (Grad. Sch. Pharmaceut. Sci., Nagoya City Univ.)
[English Session]
The Pharmaceutical Society of Japan is now working on internationalization to serve as a crucial platform for pharmaceutical sciences, primarily from Asia. In this year's annual meeting, we invite Dr. Jaehde, President of German Pharmaceutical Society, as well as speakers from Thailand, Taiwan and Canada to our international symposium. This symposium consists of five international speakers and focuses on topics of pharmacology and drug therapeutics. We would like to promote international exchanges in this symposium.
Opening Remarks
Atsushi Matsuzawa (Grad. Sch. Pharm. Sci., Tohoku Univ., Japan)
[IS02-1]Medication safety of oral anticancer therapy
○Ulrich Jaehde1,2 (1. Dept. Clin. Pharm., Pharm. Inst, Univ. Bonn, Germany, 2. President, German Pharmaceutical Society)
[IS02-2]Clinical Utility and Prognostic Value of Direct Oral Anticoagulant (DOAC) Concentration Monitoring: From Real-World Practice to Emergency Management
○Shin-Yi Lin1,2, Ching-Hua Kuo2, Yen-Bin Liu3, Sung-Chun Tang4, Jiann-Shing Jeng4 (1. Dept. Pharm., National Taiwan Univ. Hospital, Taiwan, 2. Sch. Pharm., National Taiwan Univ., Taiwan, 3. Cardiovascular Cent. Div. Intern. Med., National Taiwan Univ. Hospital, Taiwan, 4. Dept. Neurol., National Taiwan Univ., Taiwan)
[IS02-3]Ion channel-targeted therapeutics for pulmonary hypertension
○Hisao Yamamura1 (1. Grad. Sch. Pharmaceut. Sci., Nagoya City Univ., Japan)
[IS02-4]Pharmacokinetics of Psilocybin/Psilocin in magic mushroom and dimethyltryptamine in Ayahuasca using PBPK modeling approach
○Manupat Lohitnavy1 (1. Center of Excellence for Environmental Health & Toxicology, Fac. Pharm. Sci., Naresuan Univ., Thailand)
[IS02-5]Studying vascular diseases using different research modalities to determine treatment options
○Noriko Daneshtalab1 (1. Sch. Pharm., Memorial Univ. Newfoundland, Canada)
